UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Pinnacle Bancorp Inc.

Pinnacle Bancorp Inc. lowered its position in shares of UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 1.5% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 2,051 shares of the healthcare conglomerate’s stock after selling 32 shares during the period. Pinnacle Bancorp Inc.’s holdings in UnitedHealth Group were worth $1,080,000 as of its most recent filing with the SEC.

Other institutional investors have also modified their holdings of the company. Robbins Farley bought a new position in UnitedHealth Group in the 3rd quarter valued at about $25,000. Richelieu Gestion SA bought a new position in UnitedHealth Group in the 4th quarter valued at about $26,000. CGC Financial Services LLC grew its position in UnitedHealth Group by 1,000.0% in the 4th quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after buying an additional 50 shares in the last quarter. NewSquare Capital LLC grew its position in UnitedHealth Group by 340.0% in the 3rd quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate’s stock valued at $33,000 after buying an additional 51 shares in the last quarter. Finally, LFA Lugano Financial Advisors SA grew its position in UnitedHealth Group by 148.1% in the 4th quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock valued at $35,000 after buying an additional 40 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts recently issued reports on the stock. Piper Sandler decreased their target price on shares of UnitedHealth Group from $584.00 to $581.00 and set an “overweight” rating for the company in a research report on Wednesday, January 17th. Stephens reissued an “overweight” rating and issued a $605.00 price target on shares of UnitedHealth Group in a report on Thursday, February 8th. Morgan Stanley cut their price target on shares of UnitedHealth Group from $618.00 to $584.00 and set an “overweight” rating for the company in a report on Friday. Bank of America reissued a “buy” rating and issued a $675.00 price target on shares of UnitedHealth Group in a report on Thursday, March 7th. Finally, Royal Bank of Canada reissued an “outperform” rating and issued a $596.00 price target on shares of UnitedHealth Group in a report on Thursday, February 29th. Three investment analysts have rated the stock with a hold rating, sixteen have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $576.90.

Read Our Latest Stock Analysis on UNH

UnitedHealth Group Price Performance

NYSE UNH opened at $456.00 on Tuesday. The company has a 50 day simple moving average of $497.14 and a 200-day simple moving average of $518.00. The company has a debt-to-equity ratio of 0.62, a current ratio of 0.79 and a quick ratio of 0.79. The firm has a market capitalization of $420.40 billion, a price-to-earnings ratio of 19.13, a price-to-earnings-growth ratio of 1.24 and a beta of 0.54. UnitedHealth Group Incorporated has a 52-week low of $445.68 and a 52-week high of $554.70.

UnitedHealth Group (NYSE:UNHGet Free Report) last posted its quarterly earnings results on Friday, January 12th. The healthcare conglomerate reported $6.16 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $5.98 by $0.18. UnitedHealth Group had a net margin of 6.02% and a return on equity of 26.39%. The business had revenue of $94.43 billion during the quarter, compared to analyst estimates of $92.13 billion. During the same period in the prior year, the firm earned $5.34 earnings per share. The firm’s revenue was up 14.1% compared to the same quarter last year. Equities research analysts predict that UnitedHealth Group Incorporated will post 27.78 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 19th. Investors of record on Monday, March 11th were issued a $1.88 dividend. The ex-dividend date of this dividend was Friday, March 8th. This represents a $7.52 dividend on an annualized basis and a yield of 1.65%. UnitedHealth Group’s dividend payout ratio is currently 31.54%.

Insider Buying and Selling

In related news, EVP Erin Mcsweeney sold 1,236 shares of the stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the transaction, the executive vice president now owns 9,364 shares in the company, valued at $4,527,306.72. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of the stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the transaction, the executive vice president now owns 9,364 shares in the company, valued at $4,527,306.72. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, CAO Thomas E. Roos sold 858 shares of the stock in a transaction that occurred on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the transaction, the chief accounting officer now owns 32,289 shares in the company, valued at approximately $16,977,233.31. The disclosure for this sale can be found here. 0.35% of the stock is currently owned by corporate insiders.

UnitedHealth Group Company Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

See Also

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.